Skip to main content
Top
Published in: Inflammation 2/2022

01-04-2022 | Nerve Injury | Original Article

Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models

Authors: Cheng Hu, Menglin He, Meijuan Chen, Qian Xu, Sha Li, Yaomei Cui, Xizi Qiu, Weiqian Tian

Published in: Inflammation | Issue 2/2022

Login to get access

Abstract—

Neuropathic pain (NP) treatment remains a challenge because the pathomechanism is not yet fully understood. Because of low treatment efficacy, there is an important unmet need in neuropathic pain patients, and the development of a more effective pharmacotherapy is urgently required. Neuroinflammation induced by oxidative stress-mediated activation of nuclear factor-kappa B (NF-κB) plays an important role in NP. In this study, we aimed to investigate the protective properties of tetrahydropalmatine (THP) on a spared nerve injury (SNI) model of neuropathic pain in mice in in vivo and also in in vitro experiments. THP decreased mechanical hyperalgesia and cold allodynia compared with the SNI group. A microarray was applied to analyze differentially expressed of mRNA among different groups, and THP noticeably changed the expression of MAPK-related proteins compared with the SNI groups. H&E staining showed that the THP changed the inflammation after the spared nerve injury, with decreased NO expression in the THP group as compared to the SNI group. In addition, SNI-induced pain was reversed by intraperitoneal administration of THP, and further results indicated that THP suppressed inducible nitric oxide synthase (iNOS, pro-nociceptive mediators), phosphorylated MAPKs, and p65 in the dorsal root ganglions and sciatic nerve, while the serum levels of the pro-inflammatory cytokines IL-1β were significantly higher in the SNI group as compared to the THP group. To identify the molecular mechanism of the antineuropathic activity of THP, sodium nitroprusside (SNP)-induced neuro-2a (N2a) cells, LPS-induced BV2 cells, and LTA-induced astrocytes were further investigated in signaling pathways. In vitro experiments indicated that THP suppressed the expression of IL-1β, iNOS, phosphorylated MAPKs, and p65, which were assayed using western blotting, and immunofluorescence.
Literature
1.
go back to reference Lee, G.I., and M.W. Neumeister. 2020. Pain: Pathways and physiology. Clinics in plastic surgery 47: 173–180.CrossRef Lee, G.I., and M.W. Neumeister. 2020. Pain: Pathways and physiology. Clinics in plastic surgery 47: 173–180.CrossRef
2.
go back to reference Widerstrom-Noga, E. 2017. Neuropathic pain and spinal cord injury: Phenotypes and pharmacological management. Drugs 77: 967–984.CrossRef Widerstrom-Noga, E. 2017. Neuropathic pain and spinal cord injury: Phenotypes and pharmacological management. Drugs 77: 967–984.CrossRef
3.
go back to reference Wang, K., S. Wang, Y. Chen, D. Wu, X. Hu, Y. Lu, et al. 2021. Single-cell transcriptomic analysis of somatosensory neurons uncovers temporal development of neuropathic pain. Cell research. Wang, K., S. Wang, Y. Chen, D. Wu, X. Hu, Y. Lu, et al. 2021. Single-cell transcriptomic analysis of somatosensory neurons uncovers temporal development of neuropathic pain. Cell research.
4.
go back to reference Pang, H., Y. Ren, H. Li, C. Chen, X. Zheng. 2020. LncRNAs linc00311 and AK141205 are identified as new regulators in STAT3-mediated neuropathic pain in bCCI rats. European journal of pharmacology 868: 172880. Pang, H., Y. Ren, H. Li, C. Chen, X. Zheng. 2020. LncRNAs linc00311 and AK141205 are identified as new regulators in STAT3-mediated neuropathic pain in bCCI rats. European journal of pharmacology 868: 172880.
5.
go back to reference Rocha, P.A., A.F.B. Ferreira, J.T. Da Silva, A.S. Alves, D.O. Martins, L.R.G. Britto, et al. 2020. Effects of selective inhibition of nNOS and iNOS on neuropathic pain in rats. Molecular and cellular neurosciences 105: 103497. Rocha, P.A., A.F.B. Ferreira, J.T. Da Silva, A.S. Alves, D.O. Martins, L.R.G. Britto, et al. 2020. Effects of selective inhibition of nNOS and iNOS on neuropathic pain in rats. Molecular and cellular neurosciences 105: 103497.
6.
go back to reference Vannini, F., K. Kashfi, and N. Nath. 2015. The dual role of iNOS in cancer. Redox biology 6: 334–343.CrossRef Vannini, F., K. Kashfi, and N. Nath. 2015. The dual role of iNOS in cancer. Redox biology 6: 334–343.CrossRef
7.
go back to reference Lind, M., A. Hayes, M. Caprnda, D. Petrovic, L. Rodrigo, P. Kruzliak, et al. 2017. Inducible nitric oxide synthase: good or bad? Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 93: 370–375. Lind, M., A. Hayes, M. Caprnda, D. Petrovic, L. Rodrigo, P. Kruzliak, et al. 2017. Inducible nitric oxide synthase: good or bad? Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 93: 370–375.
8.
go back to reference Dai, W.L., Y.N. Bao, J.F. Fan, S.S. Li, W.L. Zhao, B.Y. Yu, et al. 2020. Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-kappaB signaling pathways in rat spinal cord. Regional anesthesia and pain medicine 45: 219–229.CrossRef Dai, W.L., Y.N. Bao, J.F. Fan, S.S. Li, W.L. Zhao, B.Y. Yu, et al. 2020. Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-kappaB signaling pathways in rat spinal cord. Regional anesthesia and pain medicine 45: 219–229.CrossRef
9.
go back to reference Ji, R.R., T. Berta, and M. Nedergaard. 2013. Glia and pain: Is chronic pain a gliopathy? Pain 154 (Suppl 1): S10–S28.CrossRef Ji, R.R., T. Berta, and M. Nedergaard. 2013. Glia and pain: Is chronic pain a gliopathy? Pain 154 (Suppl 1): S10–S28.CrossRef
10.
go back to reference Chu, L.W., K.I. Cheng, J.Y. Chen, Y.C. Cheng, Y.C. Chang, J.L. Yeh, et al. 2020. Loganin prevents chronic constriction injury-provoked neuropathic pain by reducing TNF-alpha/IL-1beta-mediated NF-kappaB activation and Schwann cell demyelination. Phytomedicine: International journal of phytotherapy and phytopharmacology 67: 153166. Chu, L.W., K.I. Cheng, J.Y. Chen, Y.C. Cheng, Y.C. Chang, J.L. Yeh, et al. 2020. Loganin prevents chronic constriction injury-provoked neuropathic pain by reducing TNF-alpha/IL-1beta-mediated NF-kappaB activation and Schwann cell demyelination. Phytomedicine: International journal of phytotherapy and phytopharmacology 67: 153166.
11.
go back to reference Zhang, X., Z. Guan, X. Wang, D. Sun, D. Wang, Y. Li, et al. 2020. Curcumin alleviates oxaliplatin-induced peripheral neuropathic pain through inhibiting oxidative stress-mediated activation of NF-kappaB and mitigating inflammation. Biological & pharmaceutical bulletin 43: 348–355.CrossRef Zhang, X., Z. Guan, X. Wang, D. Sun, D. Wang, Y. Li, et al. 2020. Curcumin alleviates oxaliplatin-induced peripheral neuropathic pain through inhibiting oxidative stress-mediated activation of NF-kappaB and mitigating inflammation. Biological & pharmaceutical bulletin 43: 348–355.CrossRef
12.
go back to reference Yehia, R., S. Saleh, H. El Abhar, A.S. Saad, and M. Schaalan. 2019. L-Carnosine protects against oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-kappaB pathways. Toxicology and applied pharmacology 365: 41–50.CrossRef Yehia, R., S. Saleh, H. El Abhar, A.S. Saad, and M. Schaalan. 2019. L-Carnosine protects against oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-kappaB pathways. Toxicology and applied pharmacology 365: 41–50.CrossRef
13.
go back to reference Popiolek-Barczyk, K., N. Kolosowska, A. Piotrowska, W. Makuch, E. Rojewska, A.M. Jurga, et al. 2015. Parthenolide relieves pain and promotes M2 microglia/macrophage polarization in rat model of neuropathy. Neural plasticity 2015: 676473. Popiolek-Barczyk, K., N. Kolosowska, A. Piotrowska, W. Makuch, E. Rojewska, A.M. Jurga, et al. 2015. Parthenolide relieves pain and promotes M2 microglia/macrophage polarization in rat model of neuropathy. Neural plasticity 2015: 676473.
14.
go back to reference Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109–110.CrossRef Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109–110.CrossRef
15.
go back to reference Cichon, J., L. Sun, G. Yang. 2018 Spared nerve injury model of neuropathic pain in mice. Bio-protocol 8. Cichon, J., L. Sun, G. Yang. 2018 Spared nerve injury model of neuropathic pain in mice. Bio-protocol 8.
16.
go back to reference ArunaDevi, R., V.D. Ramteke, S. Kumar, M.K. Shukla, S. Jaganathan, D. Kumar, et al. 2010. Neuroprotective effect of s-methylisothiourea in transient focal cerebral ischemia in rat. Nitric oxide : Biology and chemistry 22: 1–10.CrossRef ArunaDevi, R., V.D. Ramteke, S. Kumar, M.K. Shukla, S. Jaganathan, D. Kumar, et al. 2010. Neuroprotective effect of s-methylisothiourea in transient focal cerebral ischemia in rat. Nitric oxide : Biology and chemistry 22: 1–10.CrossRef
17.
go back to reference Chaplan, S.R., F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh. 1994. Quantitative assessment of tactile allodynia in the rat paw. Journal of neuroscience methods 53: 55–63.CrossRef Chaplan, S.R., F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh. 1994. Quantitative assessment of tactile allodynia in the rat paw. Journal of neuroscience methods 53: 55–63.CrossRef
18.
go back to reference Ruan, Y., L. Gu, J. Yan, J. Guo, X. Geng, H. Shi, et al. 2018. An effective and concise device for detecting cold allodynia in mice. Scientific reports 8: 14002.CrossRef Ruan, Y., L. Gu, J. Yan, J. Guo, X. Geng, H. Shi, et al. 2018. An effective and concise device for detecting cold allodynia in mice. Scientific reports 8: 14002.CrossRef
19.
go back to reference Khan, S., R.J. Choi, J. Lee, and Y.S. Kim. 2016. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative, anomalin in animal and cellular models. European journal of pharmacology 774: 95–104.CrossRef Khan, S., R.J. Choi, J. Lee, and Y.S. Kim. 2016. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative, anomalin in animal and cellular models. European journal of pharmacology 774: 95–104.CrossRef
20.
go back to reference Yan, A., Z. Liu, L. Song, X. Wang, Y. Zhang, N. Wu, et al. 2018. Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson’s disease mice. Frontiers in cellular neuroscience 12: 529.CrossRef Yan, A., Z. Liu, L. Song, X. Wang, Y. Zhang, N. Wu, et al. 2018. Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson’s disease mice. Frontiers in cellular neuroscience 12: 529.CrossRef
21.
go back to reference Nam, H.Y., J.H. Nam, G. Yoon, J.Y. Lee, Y. Nam, H.J. Kang, et al. 2018. Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice. Journal of Neuroinflammation 15: 271.CrossRef Nam, H.Y., J.H. Nam, G. Yoon, J.Y. Lee, Y. Nam, H.J. Kang, et al. 2018. Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice. Journal of Neuroinflammation 15: 271.CrossRef
22.
go back to reference Choi, B., M. Soh, Y. Manandhar, D. Kim, S.I. Han, S. Baik, et al. 2019. Highly selective microglial uptake of ceria-zirconia nanoparticles for enhanced analgesic treatment of neuropathic pain. Nanoscale 11: 19437–19447.CrossRef Choi, B., M. Soh, Y. Manandhar, D. Kim, S.I. Han, S. Baik, et al. 2019. Highly selective microglial uptake of ceria-zirconia nanoparticles for enhanced analgesic treatment of neuropathic pain. Nanoscale 11: 19437–19447.CrossRef
23.
go back to reference Kim, D.H., H. Li, Y.E. Han, J.H. Jeong, H.J. Lee, and J.H. Ryu. 2018. Modulation of inducible nitric oxide synthase expression in LPS-stimulated BV-2 microglia by prenylated chalcones from Cullen corylifolium (L.) Medik. through Inhibition of I-kappaBalpha Degradation. Molecules 23. Kim, D.H., H. Li, Y.E. Han, J.H. Jeong, H.J. Lee, and J.H. Ryu. 2018. Modulation of inducible nitric oxide synthase expression in LPS-stimulated BV-2 microglia by prenylated chalcones from Cullen corylifolium (L.) Medik. through Inhibition of I-kappaBalpha Degradation. Molecules 23.
24.
go back to reference Doyen, P.J., M. Vergouts, A. Pochet, N. Desmet, S. van Neerven, G. Brook, et al. 2017. Inflammation-associated regulation of RGS in astrocytes and putative implication in neuropathic pain. Journal of Neuroinflammation 14: 209.CrossRef Doyen, P.J., M. Vergouts, A. Pochet, N. Desmet, S. van Neerven, G. Brook, et al. 2017. Inflammation-associated regulation of RGS in astrocytes and putative implication in neuropathic pain. Journal of Neuroinflammation 14: 209.CrossRef
25.
go back to reference Mai, L., X. Zhu, F. Huang, H. He, W. Fan. 2020. p38 mitogen-activated protein kinase and pain. Life sciences 256: 117885. Mai, L., X. Zhu, F. Huang, H. He, W. Fan. 2020. p38 mitogen-activated protein kinase and pain. Life sciences 256: 117885.
26.
go back to reference Ding, S.L., Z.Y. Pang, X.M. Chen, Z. Li, X.X. Liu, Q.L. Zhai, et al. 2020. Urolithin a attenuates IL-1beta-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-kappaB signaling pathways in rat articular chondrocytes. Journal of inflammation 17: 13.CrossRef Ding, S.L., Z.Y. Pang, X.M. Chen, Z. Li, X.X. Liu, Q.L. Zhai, et al. 2020. Urolithin a attenuates IL-1beta-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-kappaB signaling pathways in rat articular chondrocytes. Journal of inflammation 17: 13.CrossRef
27.
go back to reference Xiang, H.C., L.X. Lin, X.F. Hu, H. Zhu, H.P. Li, R.Y. Zhang, et al. 2019. AMPK activation attenuates inflammatory pain through inhibiting NF-kappaB activation and IL-1beta expression. Journal of Neuroinflammation 16: 34.CrossRef Xiang, H.C., L.X. Lin, X.F. Hu, H. Zhu, H.P. Li, R.Y. Zhang, et al. 2019. AMPK activation attenuates inflammatory pain through inhibiting NF-kappaB activation and IL-1beta expression. Journal of Neuroinflammation 16: 34.CrossRef
28.
go back to reference Cinelli, M.A., H.T. Do, G.P. Miley, and R.B. Silverman. 2020. Inducible nitric oxide synthase: Regulation, structure, and inhibition. Medicinal research reviews 40: 158–189.CrossRef Cinelli, M.A., H.T. Do, G.P. Miley, and R.B. Silverman. 2020. Inducible nitric oxide synthase: Regulation, structure, and inhibition. Medicinal research reviews 40: 158–189.CrossRef
29.
go back to reference Ahlawat, A., and S. Sharma. 2018. A new promising simultaneous approach for attenuating type II diabetes mellitus induced neuropathic pain in rats: INOS inhibition and neuroregeneration. European journal of pharmacology 818: 419–428.CrossRef Ahlawat, A., and S. Sharma. 2018. A new promising simultaneous approach for attenuating type II diabetes mellitus induced neuropathic pain in rats: INOS inhibition and neuroregeneration. European journal of pharmacology 818: 419–428.CrossRef
30.
go back to reference Ramesh, G., M.T. Philipp, L. Vallieres, A.G. MacLean, and M. Ahmad. 2013. Mediators of neuroinflammation. Mediators of inflammation 2013: 314261. Ramesh, G., M.T. Philipp, L. Vallieres, A.G. MacLean, and M. Ahmad. 2013. Mediators of neuroinflammation. Mediators of inflammation 2013: 314261.
31.
go back to reference Symons, K.T., P.M. Nguyen, M.E. Massari, J.V. Anzola, L.M. Staszewski, L. Wang, et al. 2011. Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases. The Journal of pharmacology and experimental therapeutics 336: 468–478.CrossRef Symons, K.T., P.M. Nguyen, M.E. Massari, J.V. Anzola, L.M. Staszewski, L. Wang, et al. 2011. Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases. The Journal of pharmacology and experimental therapeutics 336: 468–478.CrossRef
Metadata
Title
Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models
Authors
Cheng Hu
Menglin He
Meijuan Chen
Qian Xu
Sha Li
Yaomei Cui
Xizi Qiu
Weiqian Tian
Publication date
01-04-2022
Publisher
Springer US
Published in
Inflammation / Issue 2/2022
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-021-01593-x

Other articles of this Issue 2/2022

Inflammation 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.